Envy Medical and Libbs Farmaceutical made an agreement to manufacture, market and sell Envy's proprietary Lumixyl® Brightening Creme throughout the country of Brazil.

This represents significant agreement with Libbs, a leader in the sales and supply of pharmaceutical products, it also represents a solid entry into the largest single skincare market outside of the United States.

Curtis A. Cluff, CEO of Envy Medical, Inc. said, “The population of Brazil possesses a strong and growing demand for an effective alternative to hydroquinone, and particularly one without the side effects associated with prescription hydroquinone. I am particularly excited to work with Libbs, as they are a major force and a partner of unparalleled capability, ethics and integrity."

Libbs and Envy have collaborated in developing manufacturing capabilities for Envy products in Brazil, with Libbs leading the way in executing a tailored branding and sales strategy.

For more information go to: www.envymedical.com or www.lumixyl.com.br.